B. Riley Analysts Raise Earnings Estimates for The Joint Corp. (NASDAQ:JYNT)

The Joint Corp. (NASDAQ:JYNT) – Stock analysts at B. Riley upped their Q3 2024 EPS estimates for Joint in a research report issued to clients and investors on Monday, May 6th. B. Riley analyst J. Van. Sinderen now anticipates that the company will earn $0.00 per share for the quarter, up from their previous forecast of ($0.01). B. Riley has a “Buy” rating and a $20.00 price target on the stock. The consensus estimate for Joint’s current full-year earnings is $0.13 per share. B. Riley also issued estimates for Joint’s Q4 2024 earnings at $0.04 EPS.

Other analysts also recently issued research reports about the stock. Roth Mkm reissued a “buy” rating and set a $16.00 price objective (up previously from $13.00) on shares of Joint in a report on Friday, May 3rd. TheStreet cut Joint from a “c-” rating to a “d” rating in a report on Thursday, March 7th. Finally, StockNews.com raised Joint from a “hold” rating to a “buy” rating in a report on Monday. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, Joint presently has a consensus rating of “Moderate Buy” and an average target price of $22.00.

Joint Stock Performance

Shares of NASDAQ JYNT opened at $15.93 on Tuesday. The company’s fifty day moving average is $12.42 and its two-hundred day moving average is $10.31. The firm has a market capitalization of $238.54 million, a P/E ratio of -21.24 and a beta of 1.58. Joint has a one year low of $7.31 and a one year high of $16.39.

Joint (NASDAQ:JYNT) last posted its quarterly earnings results on Thursday, March 7th. The company reported $0.07 earnings per share for the quarter, beating analysts’ consensus estimates of $0.03 by $0.04. The firm had revenue of $30.61 million for the quarter, compared to the consensus estimate of $29.63 million. Joint had a positive return on equity of 3.94% and a negative net margin of 9.24%.

Institutional Trading of Joint

Several large investors have recently modified their holdings of the business. Skylands Capital LLC lifted its stake in Joint by 20.3% in the 4th quarter. Skylands Capital LLC now owns 603,640 shares of the company’s stock valued at $5,801,000 after buying an additional 101,850 shares in the last quarter. First Foundation Advisors purchased a new stake in shares of Joint in the third quarter valued at $1,336,000. JCP Investment Management LLC boosted its stake in shares of Joint by 15.3% during the first quarter. JCP Investment Management LLC now owns 112,800 shares of the company’s stock valued at $1,473,000 after acquiring an additional 15,000 shares during the last quarter. Verus Capital Partners LLC increased its position in Joint by 24.0% during the 3rd quarter. Verus Capital Partners LLC now owns 108,370 shares of the company’s stock worth $974,000 after purchasing an additional 20,950 shares in the last quarter. Finally, O Brien Greene & Co. Inc raised its stake in Joint by 12.1% in the 3rd quarter. O Brien Greene & Co. Inc now owns 102,020 shares of the company’s stock valued at $917,000 after purchasing an additional 11,000 shares during the last quarter. 76.88% of the stock is currently owned by institutional investors and hedge funds.

Joint Company Profile

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.